Back to top
more

iShares Neuroscience and Healthcare ETF: (IBRN)

(Delayed Data from NYSE) As of Sep 15, 2025 09:34 AM ET

$25.67 USD

25.6668
53

0.00 (0.00%)

Volume: 53

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

ETF Quote Details

Previous Close 25.67
Open 25.67
Bid 13.02
Ask 39.04
Day Low-High 25.67-25.67
52wk Low-High 17.86-28.74
Volume 53
NAV (month end) 24.98
Premium (+)/Discount (-) (month end)+0.69

Zacks Premium Research for IBRN

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.47%
Dividend (Yield) $0.10 (0.39%)
Issuer BLACKROCK

Benchmark for IBRN

NYSE FACTSET GLBL NEURO BIOPH & MDTCH ID

The NYSE FactSet Global Neuro Biopharma and MedTech Index composes of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

Fund Summary for IBRN

ISHARES NEUROSCIENCE AND HEALTHCARE ETF

The iShares Neuroscience and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Neuro Biopharma and MedTech Index.